TLR9 is expressed in EAC tumors, and cytoplasmic TLR9 immunoreactivity correlates with high pathological tumor stage, positive lymph nodes, distant organ metastases, high tumor grade, tumor unresectability, and decreased 10-year survival rates [84]. Here, TLR9 is linked to neoplasm.